ALR Technologies Inc
OTC:ALRTF
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
ALR Technologies Inc
OTC:ALRTF
|
9.5m USD |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.2B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
170.7B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
140.4B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
129.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.9B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.5B EUR |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.2B USD |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.9B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.5B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
ALR Technologies Inc
Glance View
ALR Technologies, Inc. engages in the provision of remote monitoring and care facilitation for patients with diabetes. The company is headquartered in Richmond, Virginia and currently employs 6 full-time employees. The company went IPO on 2000-03-13. The firm is focused on introducing and marketing its Diabetes Management Solution for medical clinics, hospitals and healthcare providers (HCPs) to provide direct care to patients. Its Diabetes Solution consists of hardware, software and diabetes test supplies. Its ALRT Diabetes Solution is a remote monitoring and care facilitation platform that allows patients to upload the blood glucose data from their blood glucose meters on a weekly basis. The ALRT System processes and converts each data set to a predictive A1C value and shares it with the patient’s physician. The company has also developed the GluCurve Pet continuing glucose monitoring system (CGMS) to address an unmet need in diabetes care for felines and canines by combining the hardware of a CGM with the software of an adapted version of its Diabetes Solution platform for use by veterinarians in animal health.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
Over the last 0 months, ALR Technologies Inc’s Gross Margin has decreased from 66.7% to 66.7%. During this period, it reached a low of 66.7% on Jan 31, 2022 and a high of 66.7% on Jan 31, 2022.
